FDA OKs AcelRx’s pain med Dsuvia

As expected, the FDA approves AcelRx Pharmaceuticals’ (ACRX -3.7%) pain med DSUVIA (sufentanil sublingual tablet). Last month, an advisory group voted 10-3 backing approval.

https://seekingalpha.com/news/3404863-fda-oks-acelrxs-pain-med-dsuvia